| Date of change | 01 Apr 2024 |
| Name | MR YOICHIRO ENDO |
| Age | 58 |
| Gender | Male |
| Nationality | Japan |
| Designation | Non-Independent Director |
| Directorate | Non Independent and Non Executive |
| Type of change | Appointment |
Qualifications
| No | Qualifications |
Major/Field of Study |
Institute/University |
Additional Information |
|
Degree
|
Bachelor of Engineering |
Department of Applied Physics, Faculty of Engineering, The University of Tokyo |
|
| Working experience and occupation | Yoichiro Endo will take up the role of the Executive Managing Officer & Chief Operating Officer of the Wellness Business Unit at Mitsui & Co., Ltd ("Mitsui") in its Tokyo Headquarters, effective 1 April 2024.
He has over 30 years of working experience in Mitsui, mainly in the Food Business, the Buyout Fund, and the Venture Capital Investment field. He has held various executive roles in Mitsui and Mitsui's key subsidiaries. Most recently, he served as the Managing Officer and Chief Operating Officer of the Food Business Unit since April 2020 and was promoted to Executive Managing Officer in April 2023. In the field of food business, he managed various trading and investment projects such as Grain, Oil & Fats, Sugar, Animal Protein, Aquaculture, Dairy Products, Coffee & Tea, Pulses and Staple food. Before that, he was involved in launching a buyout fund and served as Chief Executive Officer ("CEO") of Mitsui & Co. Principal Investments Ltd from 2007 to 2011, which has now become a prominent buyout fund in Japan. He worked in the United States between 1991 and 2004, where he established a corporate venture capital arm of Mitsui and served as CEO of Mitsui & Co. Venture Partners, Inc., from 2001 to 2004, after having worked for Mitsui & Co.(U.S.A.), Inc. and Orien Ventures, Inc (Venture Capital, USA). He led startup investment projects, especially in IT, pharmaceuticals, and medical devices. |
| Directorships in public companies and listed issuers (if any) | NIL |
| Family relationship with any director and/or major shareholder of the listed issuer | NIL |
| Any conflict of interests that he/she has with the listed issuer | NIL |
| Details of any interest in the securities of the listed issuer or its subsidiaries | NIL |
Announcement Info
| Company Name | IHH HEALTHCARE BERHAD |
| Stock Name | IHH |
| Date Announced | 29 Mar 2024 |
| Category | Change in Boardroom |
| Reference Number | C03-15032024-00003 |